Protective Packaging Solutions for Pharmaceutical Product Stability
The challenge for pharmaceutical packaging systems is medicinal product protection. ECA's Course Protective Packaging Solutions for Pharmaceutical Product Stability from 28–29 January 2014 in Berlin, Germany, will show how to improve drug stability through barrier packaging and desiccants. Practical case studies will be presented for specific packaging types and dosage forms.
Speakers:
Torsten Kneuß, Bayer Pharma AG, Germany
Dr Mayk Kresse, Bayer Pharma AG, Germany
Horst Koller, Schott Schweiz AG, Switzerland
Dr Jörg Zürcher, Bayer Pharma AG, Germany
Prof Dr Ursula Probst, Stuttgart Media University, Packaging Technology, Germany
Objectives/Background
The aim of this conference is to provide up-to-date knowledge about protective packaging solutions for the stability of pharmaceutical drug products (Barrier Packaging). Which physical fundamentals are relevant? Which measuring procedures and methods do exist? Which drying agent systems are used? By means of specific packaging types and dosage forms (blister, oral, parenteral), all these questions will be answered and practical case studies will be presented.
Moisture permeation/barrier packaging and container closure system integrity is a constant challenge and a regular work stream for expert groups such as the Product Quality Research Institute (PQRI) or the Parenteral Drug Association (PDA).
Moisture permeation is a common challenge that can impact the quality of the drug product, so having a more accurate and reproducible method to determine how effective the packaging is at keeping moisture out will be a benefit to industry. Accordingly, also USP is currently revising the packaging and moisture permeation chapters (USP General Chapter <671> Containers — Performance Testing) to include a new method for determining moisture permeation for high and low barrier pharmaceutical packaging. USP is also considering changing the USP classification system for packaging, which is limited so far to “well-closed” and “tight” containers.
Today, the appropriate packaging system is commonly chosen on a "trial & error" approach (orientating stability investigations under stress conditions). However, this "procedure" shows its limits when no appropriate packaging has been identified within this trial & error approach. Hence, only precise knowledge of the physical processes of permeation in conjunction with the material features of the packaging and the protection requirements of the dosage form will finally provide a scientific rational for the selection of the best packaging system with optimal product protection.
Moreover, regarding new regulatory options (ICH Q8), scientific understanding of critical parameters is required - for example to be able to identify critical quality attributes and to define a Design Space.
Please see the programme for further information.
Related News
-
News Closing 2024 with Editors' picks of top articles from the past year
Coming to the end of 2024 and it’s certainly been a busy year, for CPHI and for the rest of the pharmaceutical and healthcare industry. Topics of conversation throughout the last 12 months have been varied, touching on the technical, to the polit... -
News SCHOTT Pharma’s sustainable journey with CPHI
Sustainability is of paramount importance in the pharmaceutical industry. See how a recent partnership between CPHI and SCHOTT Pharma has helped to highlight and accelerate their sustainability journey to reach global goals. -
News CPHI Podcast Series: Investing in a vision for the future of life sciences
In this episode Lucy Chard is joined by Rajiv Khatau to discuss the importance of looking into new therapeutic areas and some of the more niche areas of pharmaceuticals, and investing in the future of the industry. -
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News Women in Pharma: Reflections from Behind the Scenes
In this instalment of our monthly series, the team that brings you the Women in Pharma series each month sits down for a heart-to-heart on what the series means to them, and how they hope to continue their work in the future. -
News CPHI Milan 2024: Excerpts from the Exhibitors
After another successful year of bringing the pharmaceutical community together at CPHI Milan in October, hear direct from the exhibitors on why the event is so important for them and the industry as a whole. -
News Scaling the Industry: CPHI Scale-Up Market interview with YSK Laboratories
For the first time, CPHI Milan hosted the CPHI Start-Up Market, expanding support for emerging and small-sized enterprises in their transition to the next level of growth. In this interview, we spoke with Yuvansh Khokhani, Managing Director of YSK Labo... -
News Key Insights from the Heart of Pharma: an exclusive CPHI Online report
CPHI Milan, held from October 8–10, 2024 in the historic Fiera Milano, celebrated its 35th edition of bringing together the pharmaceutical industry and supply chain for 3 days of collaborating and innovating. Our first CPHI Wrap-Up Report brings ...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance